Agreed Acquisitions: #AbbottLaboratories > #ExactSciences; #AtmusFiltrationTech > #KochFilter; #ErosInnovation > #EmpiricalWax; #GilbraltarIndustries > #StrategicValuePartners; #GoPhoto > #CaptureLife;
#Johnson&Johnson > #HaldaTherapeutics; #Merck > #Cidara; #SafeSecurity > #Balbix

Halper Sadeh LLC Urges Shareholders of CDTX, MRSN, and HOLX to Understand Their Rights Halper Sadeh LLC is urging shareholders of Cidara, Mersana, and Hologic to reach out regarding potential violations of their rights in recent transactions.

Halper Sadeh LLC Urges Shareholders of CDTX, MRSN, and HOLX to Understand Their Rights #USA #New_York #Hologic #Cidara #Mersana

Pharmalittle: We're reading about a Merck acquisition, Novo facing shareholder backlash, and more Merck agreed to buy Cidara Therapeutics, the maker of an experimental flu therapy, in a $9.2 billion deal

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a Merck acquisition, Novo facing shareholder backlash, and more news.. statnews.com/pharmalot/20... #pharma #flu #opioids #Merck #NovoNordisk #JNJ #BristolMyers #Lundbeck #Alkermes #Cidara

Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza

A non-#vaccine #flu preventative
#Cidara had success in its randomized, double-blind, placebo-controlled Phase 2b NAVIGATE trial evaluating CD388 for the prevention of seasonal #influenza in healthy unvaccinated adults aged 18 to 64.

www.biospace.com/press-releas...